# Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder

> **NCT03537950** · NA · COMPLETED · sponsor: **King's College London** · enrollment: 38 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** PLC
- **DRUG:** CBD
- **DRUG:** CBDV

## Key facts

- **NCT ID:** NCT03537950
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-22
- **Primary completion:** 2017-02-16
- **Final completion:** 2017-03-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537950, "Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03537950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*